Skip to content
FIND A HEALTH VALLEY ACTOR
FIT Septembre 2024

TWIICE and Nexco Analytics supported by the FIT

23.09.2024
Share this article

The Foundation for Technological Innovation extends its support to Twiice and Nexco Analytics with new loans. Twiice has been awarded a Tech Growth loan of CHF 400,000 for the development of its unique exoskeleton, and Nexco Analytic has been awarded a Tech Seed loan of CHF 100,000 for its software solution (Saas) to accelerate research processes in genomic analysis.

 

 

Twiice’s extremely agile exoskeleton

Since 2016, Twiice has been developing an exoskeleton that has established itself over the years as the most integrated, slimmest and lightest of all currently available on the market. This device benefits from a unique production technique based on digital manufacturing, which enables high-performance structures (light and compact) to be produced in small batches at an affordable price.
Twiice”sexoskeletons are designed for mobility assistance and rehabilitation for people suffering from spinal cord injuries, strokes, multiple sclerosis and locomotor deficiencies. Furthermore, the Twiice exoskeleton incorporates intelligent assistance that naturally ‘guides’ the patient in a perfectly measured way according to their needs
The first generation of exoskeletons currently under development will be designed for use both in clinics as a therapeutic tool (which is the current practice) and in patients’ homes under the supervision of a coach, which would be completely new.
The CHF 400,000 Tech Growth loan provided by FIT will enable Twiice to continue developing its 2nd and 3rd generation exoskeletons. These future generations will be adapted to the activities of daily life and will provide greater independence for people with reduced mobility.
 

 

Nexco Analytics: genomic analysis with digital technology

The software (Saas) developed by Nexco Analytics, called ONex, aims to make the genomic analysis process simpler, more efficient and faster by using advanced and optimised digital techniques. ONex works directly on the raw data collected (biological material) after it has been sequenced, and then processes it using artificial intelligence to rapidly deliver interpretable results and visualisations that will help researchers learn from their experiments and answer their scientific questions.
Designed to be used by a wide audience, ONex is very easy to use, requiring no prior skills in IT or data analysis. With the CHF 100,000 Tech Seed loan from the Foundation for Technological Innovation, Nexco Analytics will complete the development of its ONex SaaS, in particular by optimising its graphical interface, but also by increasing the number of sequencing technologies that the tool can support. This will be followed by the market launch of the tool.

 

Source: press release